Speaking up: how to raise concerns in the pharmacy workplace In this episode of The PJ Pod, we talk about the importance of speaking up if you have a safety or wellbeing concern and how to go about it.…
Finger-prick test for type 1 diabetes mellitus could roll out to all UK children 'Early surveillance for autoimmune diabetes’ study showed that the dried blood spot method used “was both feasible and acceptable”, researchers said.…
Pharmacies can deliver more vaccinations off-site, government confirms Under changes to the Human Medicines Regulations 2012, community pharmacies will be allowed to offer vaccination services outside registered premises.…
MPs push for more details on VPAG and NICE threshold changes The House of Commons Science Innovation and Technology Committee has asked the government for further clarification on what investment it plans to make into the ‘Voluntary scheme for branded medicines pricing, access and growth’.…
Sir Hugh Taylor: ‘We’d like to do ourselves out of a job as quickly as possible’ The Pharmaceutical Journal spoke to Sir Hugh Taylor, chair of the UK Pharmacy Professional Leadership Advisory Board, about his optimism for a collaborative future with the creation of the Royal College of Pharmacy.…
Drug consumption room pilot records more than 1,000 injecting episodes in a month According to latest service data on The Thistle, a drug consumption facility in Glasgow, 560 people used the site's services more than 10,000 times in 2025.…
Crossing borders and breaking barriers: why we need to truly value global contributions to pharmacy and healthcare Principal pharmacist Rafia Jamil shares her journey as an “overseas pharmacist” and how her experience of equality, diversity and inclusion within pharmacy has been complex but hopeful.…
Brands help patients choose most appropriate OTC drugs Nearly two-thirds of respondents to a survey by consumer healthcare association PAGB said trust in a brand influenced their decision to buy over-the-counter medicines.…
Aspirin added to list of medicines that cannot be exported from UK or hoarded The list contains medicines that have evidence or risk of critical shortages, which could adversely impact UK patients.…
Prescribing dilemma: high-cost biologics in moderate-to-severe ulcerative colitis This real-world dilemma explores how individual funding requests may need to be considered for patient-centred care in the case of high-cost biologics.…
